The Janus-faced effects of hypoxia on astrocyte function

Neuroscientist

Volumn 15, Issue 6, 2009, Pages 579-588

  Vangeison, Grace ^a   Rempe, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Astrocyte; HIF; Hypoxia; Ischemia; Preconditioning

Indexed keywords

ERYTHROPOIETIN; GLUTAMIC ACID; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; ASTROCYTE; CELL FUNCTION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; GENE EXPRESSION; HYPOXIA; NERVE CELL; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; BRAIN; CELL SURVIVAL; CYTOPROTECTION; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-ISCHEMIA, BRAIN; ISCHEMIC PRECONDITIONING; SIGNAL TRANSDUCTION;

EID: 71949092716     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858409332405     Document Type: Review

References (71)

1. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. 2000. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681-1689
2. Bak LK, Schousboe A, Waagepetersen HS. 2006. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98:641-653 (Pubitemid 44051266)
3. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC. 2007. Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27:6320-6332 (Pubitemid 46890035)
4. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, and others. 1997. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-1244
5. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, and others. 1999. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651
6. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. 2002. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22:393-403. (Pubitemid 34273595)
7. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, and others. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702-710
8. Boycott HE, Wilkinson JA, Boyle JP, Pearson HA, Peers C. 2008. Differential involvement of TNFalpha in hypoxic suppression of astrocyte glutamate transporters. Glia 56:998-1004.
9. Bruick RK. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 97:9082-9087 (Pubitemid 30626677)
10. Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, Wei C, and others. 2008. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc Res 77:463-470
11. Chavez JC, Baranova O, Lin J, Pichiule P. 2006. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26:9471-9481 (Pubitemid 44396860)
12. Cho IH, Im JY, Kim D, Kim KS, Lee JK, Han PL. 2003. Protective effects of extracellular glutathione against Zn2+-induced cell death in vitro and in vivo. J Neurosci Res 74:736-743
13. Cunningham LA, Wetzel M, Rosenberg GA. 2005. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50:329-339 (Pubitemid 40780839)
14. Dallas M, Boycott HE, Atkinson L, Miller A, Boyle JP, Pearson HA, and others. 2007. Hypoxia suppresses glutamate transport in astrocytes. J Neurosci 27:3946-3955
15. Diaz Z, Assaraf MI, Miller WH, Jr., Schipper HM. 2005. Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders. J Neurochem 93:392-402. (Pubitemid 40547496)
16. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, and others. 2005. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202:1493-1505
17. Fogal B, Li J, Lobner D, McCullough LD, Hewett SJ. 2007. System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J Neurosci 27:10094-10105 (Pubitemid 47450471)
18. Gabryel B, Malecki A. 2006. Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors. Pharmacol Rep 58:381-392
19. Gabryel B, Toborek T, Malecki A. 2005. Immunosuppressive immunophilin ligands attenuate damage in cultured rat astrocytes depleted of glutathione and exposed to simulated ischemia in vitro. Comparison with N-acetylcysteine. Neurotoxicology 26:373-384 (Pubitemid 40780014)
20. Grenz A, Zhang H, Hermes M, Eckle T, Klingel K, Huang DY, and others. 2007. Contribution of E-NTPDase1 (CD39) to renal protection from ischemiareperfusion injury. FASEB J 21:2863-2873
21. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC. 2007. Acute postnatal ablation of Hif-2{alpha} results in anemia. Proc Natl Acad Sci U S A 104:2301-2306 (Pubitemid 46391392)
22. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, and others. 1997. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A 94:2007-2012
23. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. 1995. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A 92:4666-4670
24. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, and others. 2004. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 63:84-96.
25. Iadecola C. 1997. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139 (Pubitemid 27086729)
26. Jian Liu K, Rosenberg GA. 2005. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39:71-80. (Pubitemid 40733117)
27. Jin K, Mao XO, Simon RP, Greenberg DA. 2001. Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia. J Mol Neurosci 16:49-56.
28. Jin KL, Mao XO, Greenberg DA. 2000. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 97:10242-10247 (Pubitemid 30680886)
29. Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, and others. 2008. Connexin 43 hemichannels are permeable to ATP. J Neurosci 28:4702-4711
30. Kim D, Joe CO, Han PL. 2003. Extracellular and intracellular glutathione protects astrocytes from Zn2+-induced cell death. Neuroreport 14:187-190 (Pubitemid 36308407)
31. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177-185 (Pubitemid 43316523)
32. Kleinert H, Pautz A, Linker K, Schwarz PM. 2004. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500:255-266 (Pubitemid 39304013)
33. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, Laucher S, and others. 2007. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116:1784-1794
34. Laderoute KR, Calaoagan JM, Gustafson-Brown C, Knapp AM, Li GC, Mendonca HL, and others. 2002. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol 22:2515-2523
35. Lee MY, Ju WK, Cha JH, Son BC, Chun MH, Kang JK, and others. 1999. Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats. Neurosci Lett 265:107-110
36. Lee YS, Song YS, Giffard RG, Chan PH. 2006. Biphasic role of nuclear factor-kappa B on cell survival and COX-2 expression in SOD1 Tg astrocytes after oxygen glucose deprivation. J Cereb Blood Flow Metab 26: 1076-1088
37. Levy NS, Chung S, Furneaux H, Levy AP. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273:6417-6423 (Pubitemid 28144735)
38. Lin JH, Lou N, Kang N, Takano T, Hu F, Han X, and others. 2008. A central role of connexin 43 in hypoxic preconditioning. J Neurosci 28:681-695
39. Liu J, Narasimhan P, Song YS, Nishi T, Yu F, Lee YS, and others. 2006. Epo protects SOD2-deficient mouse astrocytes from damage by oxidative stress. Glia 53:360-365
40. Malek R, Borowicz KK, Jargiello M, Czuczwar SJ. 2007. Role of nuclear factor kappaB in the central nervous system. Pharmacol Rep 59:25-33. (Pubitemid 46522699)
41. Maragakis NJ, Rothstein JD. 2004. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 15(3):461-473 (Pubitemid 38429961)
42. Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC, Kossmann T, and others. 1997. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int 51:416-418
43. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. 1994. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269:19488-19493 (Pubitemid 24978761)
44. Michiels C, Minet E, Mottet D, Raes M. 2002. Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med 33:1231-1242 (Pubitemid 35246591)
45. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. 1997. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76:105-116 (Pubitemid 26407940)
46. Nagasawa K, Kawasaki F, Tanaka A, Nagai K, Fujimoto S. 2007. Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons. Glia 55:1397-1404 (Pubitemid 47461155)
47. Nedeljkovic N, Bjelobaba I, Subasic S, Lavrnja I, Pekovic S, Stojkov D, and others. 2006. Up-regulation of ectonucleotidase activity after cortical stab injury in rats. Cell Biol Int 30:541-546
48. Ohtaki H, Takaki A, Yin L, Dohi K, Nakamachi T, Matsunaga M, and others. 2003. Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice. Acta Neurochir Suppl 86:191-194
49. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187-197 (Pubitemid 43316524)
50. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. 1999. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 58:654-666 (Pubitemid 29264945)
51. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, and others. 2003. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34:1981-1986
52. Rempe DA, Lelli KM, Vangeison G, Johnson RS, Federoff HJ. 2007. In Cultured Astrocytes, p53 and MDM2 Do Not Alter Hypoxia-inducible Factor-1{alpha} Function Regardless of the Presence of DNA Damage. J Biol Chem 282:16187-16201
53. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, and others. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453:807-811
54. Robson SC, Sevigny J, Zimmermann H. 2006. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2:409-430
55. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, and others. 2002. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22:10291-10301
56. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, and others. 1998. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95:4635-4640
57. Schmid T, Zhou J, Brune B. 2004. HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med 8:423-431 (Pubitemid 44145475)
58. Scortegagna M, Cataisson C, Martin RJ, Hicklin DJ, Schreiber RD, Yuspa SH, and others. 2008. HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 111: 3343-3354
59. Semenza GL. 2000. HIF-1:Mediator of physiological and pathophysiological responses to hypoxia. J. Appl Physiol 88:1474-1480
60. Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH, and others. 1997. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 51:553-555
61. Sinor AD, Irvin SM, Cobbs CS, Chen J, Graham SH, Greenberg DA. 1998. Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures. Brain Res 812:289-291 (Pubitemid 29005363)
62. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, and others. 2001. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98:4044-4049
63. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, and others. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor1 mediates permeability changes in intestinal epithelia. J Clin Invest 110:993-1002.
64. Vangeison G, Carr D, Federoff HJ, Rempe DA. 2008. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1alpha in neurons and astrocytes. J Neurosci 28:1988-1993 (Pubitemid 351302661)
65. Wardas J. 2002. Neuroprotective role of adenosine in the CNS. Pol J Pharmacol 54:313-326
66. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB. 2002. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22:6401-6407 (Pubitemid 35386396)
67. Wink MR, Braganhol E, Tamajusuku AS, Lenz G, Zerbini LF, Libermann TA, and others. 2006. Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 138:421-432
68. Yang GY, Zhao YJ, Davidson BL, Betz AL. 1997. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 751:181-188
69. Zhang W, Petrovic JM, Callaghan D, Jones A, Cui H, Howlett C, and others. 2006. Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures. J Neuroimmunol 174:63-73.
70. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, and others. 2000. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106:829-838
71. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, and others. 2006. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441-445